Indrayani Biotech share news and announcements
BSE: 526445Agricultural Food & other ProductsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹8.77.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹38 Cr3,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 Sep 2026
- 0.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Oct 2026
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 Sep 2026
- 1.26
- Volume, BSEVolume. Shares traded on the last trading day.
- 19,910
Indrayani Biotech share news and announcements
608 announcements, routine notices left out, newest first. Page 5 of 13.
May 2023
Apr 2023
28 Apr · Compliances-Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2023
20 Apr · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
13 Apr · Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 - Intention To Invest In A Company By IBL Healthcare Limited, A Wholly Owned Subsidiary Of Indrayani Biotech Limited.
13 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended March 31, 2023.
13 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Mar 2023
2 Mar · Intimation Of Amendment In Code Of Fair Disclosure Of Unpublished Price Sensitive Information Policy Of The Company.
1 Mar · Intimation Of Amendment In Code Of Fair Disclosure Of Unpublished Price Sensitive Information Policy Of The Company
Feb 2023
16 Feb · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
6 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Jan 2023
13 Jan · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Operation Management Of Vaasan Medical Center (India) Private Limited.
Dec 2022
10 Dec · Intimation Of Compliance Officer Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Nov 2022
27 Nov · Disclosure On Related Party Transactions For The Half Year Ended September 30, 2022.
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results1 Nov · Disclosure Regarding Intimation Of Delivery Of Work Order
Oct 2022
14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 03 Oct · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Sep 2022
Aug 2022
30 Aug · Board meeting
Meeting on 5 Sep 2022: annual general meeting19 Aug · Disclosure With Respect To Receipt Of Work Order.
8 Aug · Board meeting
Meeting on 13 Aug 2022: quarterly results
Jul 2022
22 Jul · Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Jun 2022
30 Jun · Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements)Regulations, 2015.
28 Jun · Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (LODR) Regulations, 2015.
2 Jun · Intimation With Respect To Conversion Of Our Wholly Owned Subsidiary Companies From Private Limited To Public Limited.